Impact of azithromycin on specific biochemical markers and sebum composition in acne vulgaris patients
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-025-04299-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Alaa Sh Abdulbari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Applied Sciences, University of Technology- Iraq, Baghdad, Iraq. Hauptthemen laut MEDLINE: Azithromycin, Acne Vulgaris, Sebum, Anti-Bacterial Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Acne vulgaris (AV) is a persistent inflammatory skin disease that affects the pilosebaceous units. Oral azithromycin has shown significant effectiveness in treating AV, attributed to its robust anti-inflammatory and antimicrobial properties. This study aimed to evaluate the efficacy of azithromycin in patients with moderate-to-severe AV, with a focus on its influence on sebum composition and specific biomarkers, including pyridoxine (B6), biotin (B7), cobalamin (B12) (measured by HPLC), and homocysteine (measured by ELISA). A case-control study was conducted at the dermatology department of Al-Imamain-Alkadhimain Medical City, Baghdad. The study included thirty patients aged 15-35 years with moderate-to-severe AV, and thirty healthy individuals of the same age and sex served as a control group. Patients received 500 mg of azithromycin on alternate days for 12 weeks. Laboratory and clinical parameters were assessed at baseline and compared to the control group, then re-evaluated after treatment. The findings indicated a significant decrease in serum levels of folic acid, B7, and B6 at both 6 and 12 weeks post-treatment (p 0.05). No significant difference in serum B12 levels was observed at 6 weeks (p > 0.05); however, a significant increase was noted at 12 weeks (p < 0.05). Clinical score, skin moisture, and sebum squalene (Sebum-SQ) content improved significantly post-treatment (p < 0.05), while sebum cholesterol (Sebum-Chol.) levels showed significant change only at 12 weeks (p < 0.05). The finding supports the efficacy of azithromycin in managing inflammatory acne and modulating sebum composition and specific biomarkers. However, the relatively small sample size and absence of power analysis limit the generalizability of the results. Future studies with larger cohorts are recommended to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Applied Sciences, University of Technology- Iraq, Baghdad, Iraq.
- Department of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq.
- Department of Pharmacology, College of Medicine, AL-Nahrain University, Baghdad, Iraq.
- Section of Dermatology & Venereology, College of Medicine, AL-Nahrain University, Baghdad, Iraq.
- College of Pharmacy, Al-Mustaqbal University, Hillah, Babylon, 51001, Iraq. hayder80.ridha@gmail.com.
Zitieren
APA
Abdulbari, A. S., Ali, N. M., Abu-Raghif, A. R., Matloob, N. A., & Ridha-Salman, H. (2025). Impact of azithromycin on specific biochemical markers and sebum composition in acne vulgaris patients. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04299-4
Vancouver
Abdulbari AS, Ali NM, Abu-Raghif AR, Matloob NA, Ridha-Salman H. Impact of azithromycin on specific biochemical markers and sebum composition in acne vulgaris patients. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04299-4
BibTeX
@article{Abdulbari2025,
author = {Abdulbari, Alaa Sh and Ali, Noor M and Abu-Raghif, Ahmed Rahmah and Matloob, Nadheer A and Ridha-Salman, Hayder},
title = {Impact of azithromycin on specific biochemical markers and sebum composition in acne vulgaris patients},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-025-04299-4}
}
EUVIMED